Development of the Meharry Medical College Prostate Cancer Research Program
Annual rept. 1 Mar 2006-28 Feb 2007
MEHARRY MEDICAL COLL NASHVILLE TN
Pagination or Media Count:
There is substantial urology, oncology, epidemiology, nutrition and other expertise at Meharry and Vanderbilt to address issues relating to prostate cancer PCa disparity among African-American AA men. Six newjunior minority investigators have initiated pilot projects, continue to maintain partnerships with mentors at VU, and two PIs have established viable community network ties. Dr. Ukoli has recruited 64 participants into the lycopene study, sent 200 stored plasma samples for lycopene analysis, and developed a lycopene clinical trial to be submitted in June. Dr. Washington has recruited 14 participants into the PCa health care seeking behavior study. 300 blood samples of AA and Nigerians will be sent to the GCRC at VU for DNA extraction and genotyping for Dr. Cui s study in collaboration with Dr. Marshall new investigator. Dr. Ogunkua has dosed sacrificed 40 mice recording data at all time-points. Dr. Stewart has received independent funding for the PCa cell lines Thalidomide growth inhibitory study, and two students have submitted pre-doctoral grants from her laboratory. Dr. Abu, postdoctoral fellow, has developed a career development award proposal to look at quality of life following PCa treatment to be submitted in June. 2 MSPH graduate students have selected related topics for their thesis.
- Anatomy and Physiology
- Medicine and Medical Research